{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:37:12Z","timestamp":1788565032469,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.xphs.2021.08.034","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:56:16Z","timestamp":1630461376000},"page":"3851-3861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dual Responsive Hybrid Nanoparticle for Tumor Chemotherapy Combined with Photothermal Therapy"],"prefix":"10.1016","volume":"110","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2021.08.034_bib0002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12916-016-0623-5","article-title":"Cancer immunotherapy: the beginning of the end of cancer?","volume":"14","author":"Farkona","year":"2016","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.xphs.2021.08.034_bib0003","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1158\/1078-0432.CCR-14-2339","article-title":"The BRAF and MEK inhibitors Dabrafenib and Trametinib: effects on immune function and in combination with immunomodulatory antibodies targeting PD-1, PD-L1, and CTLA-4","volume":"21","author":"Liu","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.034_bib0004","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"02","key":"10.1016\/j.xphs.2021.08.034_bib0005","first-page":"218","article-title":"Research progress of targeted drug delivery systems","author":"Ning","year":"2017","journal-title":"J Liaoning Univ Tradition Chin Med"},{"issue":"302","key":"10.1016\/j.xphs.2021.08.034_bib0006","first-page":"63","article-title":"Modulation of pericytes by a fusion protein comprising of a PDGFR\u03b2-antagonistic affibody and TNF-\u03b1 induces tumor vessel normalization and improves chemotherapy","volume":"28","author":"Q-Fan-Z-Tao","year":"2019","journal-title":"J Controlled Rel"},{"issue":"30","key":"10.1016\/j.xphs.2021.08.034_bib0007","doi-asserted-by":"crossref","first-page":"26529","DOI":"10.1021\/acsami.9b01370","article-title":"Boosting Cancer Therapy with Organelle-Targeted Nanomaterials","volume":"11","author":"Gao","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.xphs.2021.08.034_bib0008","first-page":"130209","article-title":"MSC and Tumors: homing, differentiation, and secretion influence therapeutic potential","author":"Souza","year":"2013","journal-title":"Adv Biochem Eng Biotechnol"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.034_bib0009","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/stem.2579","article-title":"Concise review: emerging drugs targeting epithelial cancer stem-like cells","volume":"35","author":"Ahmed","year":"2017","journal-title":"Stem Cells"},{"issue":"31","key":"10.1016\/j.xphs.2021.08.034_bib0010","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1002\/smll.201601137","article-title":"Multifunctional mesoporous silica nanoparticles with thermal-responsive gatekeeper for NIR light-triggered chemo\/photothermal-therapy","volume":"12","author":"Lei","year":"2016","journal-title":"Small"},{"key":"10.1016\/j.xphs.2021.08.034_bib0011","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejmech.2017.08.063","article-title":"Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: a promising in vivo drug delivery system for colorectal cancer therapy","volume":"142","author":"Lee","year":"2017","journal-title":"Eur J Med Chem"},{"issue":"253","key":"10.1016\/j.xphs.2021.08.034_bib0012","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.micromeso.2017.06.042","article-title":"Heat shock responsive drug delivery system based on mesoporous silica nanoparticles coated with temperature sensitive gatekeeper","volume":"6","author":"Cho","year":"2017","journal-title":"Microporous Mesoporous Mater"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2021.08.034_bib0013","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ijpharm.2017.06.043","article-title":"Design and development of multi-walled carbon nanotube-liposome drug delivery platforms","volume":"528","author":"Pippa","year":"2017","journal-title":"Int J Pharm"},{"issue":"6857","key":"10.1016\/j.xphs.2021.08.034_bib0014","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/35099513","article-title":"Suppression of crystal nucleation in polydisperse colloids due to increase of the surface free energy","volume":"413","author":"Frenkel-D Auer","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.xphs.2021.08.034_bib0015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0030-4018(87)90145-3","article-title":"Degenerate four-wave mixing of CdS\/polymer composite","volume":"61","author":"Ying","year":"1987","journal-title":"Opt Commun"},{"issue":"16","key":"10.1016\/j.xphs.2021.08.034_bib0016","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1103\/PhysRevLett.52.1453","article-title":"Coulomb suppression of tunneling rate from small metal particles","volume":"52","author":"Cavicchi","year":"1984","journal-title":"Phys Rev Lett"},{"issue":"2","key":"10.1016\/j.xphs.2021.08.034_bib0017","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1359-0286(97)80069-1","article-title":"Quantum tunneling effect in magnetic particles","volume":"2","author":"Barbara","year":"1997","journal-title":"Curr Opin Solid State Mater Sci"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.034_bib0018","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1385\/MB:25:1:37","article-title":"Laser immunotherapy: a novel treatment modality for metastatic tumors","volume":"25","author":"Chen","year":"2003","journal-title":"Mol Biotechnol"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.034_bib0019","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.actbio.2016.04.024","article-title":"Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography","volume":"38","author":"Feng","year":"2016","journal-title":"Acta Biomater"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.034_bib0020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI40269","article-title":"Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice","volume":"120","author":"Ramakrishnan","year":"2010","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.034_bib0021","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1385\/MB:25:1:37","article-title":"Laser immunotherapy: a novel treatment modality for metastatic tumors","volume":"25","author":"Chen","year":"2003","journal-title":"Mol. Biotechnol"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.034_bib0022","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2009.356","article-title":"Immunogenic death of colon cancer cells treated with oxaliplatin","volume":"29","author":"Tesniere","year":"2010","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.xphs.2021.08.034_bib0023","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s00262-012-1307-4","article-title":"Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo","volume":"61","author":"Jackaman","year":"2012","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.034_bib0024","first-page":"5","article-title":"Hydroxyapatites enriched in silicon \u2013 bioceramic materials for biomedical and pharmaceutical applications","author":"Szurkowska","year":"2017","journal-title":"Progr Nat Sci"},{"issue":"19","key":"10.1016\/j.xphs.2021.08.034_bib0025","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/smll.201402145","article-title":"Gold nanorods coated with mesoporous silica shell as drug delivery system for remote near infrared light-activated release and potential phototherapy","volume":"11","author":"Ji","year":"2015","journal-title":"Small"},{"issue":"15","key":"10.1016\/j.xphs.2021.08.034_bib0026","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1021\/ja3123015","article-title":"Controllable drug release and simultaneously carrier decomposition of SiO2-drug composite nanoparticles","volume":"135","author":"Zhang","year":"2013","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.034_bib0027","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmat2398","article-title":"Biodegradable luminescent porous silicon nanoparticles for in vivo applications","volume":"8","author":"Park","year":"2009","journal-title":"Nat Mater"},{"issue":"34","key":"10.1016\/j.xphs.2021.08.034_bib0028","doi-asserted-by":"crossref","first-page":"13997","DOI":"10.1021\/ja3036114","article-title":"Iron(III)-Doped, Silica Nanoshells: a Biodegradable Form of Silica","volume":"134","author":"Kristina","year":"2012","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.034_bib0029","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2021.08.034_bib0030","doi-asserted-by":"crossref","first-page":"9614","DOI":"10.1021\/nn507485j","article-title":"Hybrid mesoporous silica-based drug carrier nanostructures with improved degradability by hydroxyapatite","volume":"9","author":"Yang","year":"2015","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.xphs.2021.08.034_bib0032","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1021\/nn200365a","article-title":"The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo","volume":"5","author":"Huang","year":"2011","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.xphs.2021.08.034_bib0033","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1021\/ja907838s","article-title":"pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker","volume":"132","author":"Liu","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.xphs.2021.08.034_bib0034","doi-asserted-by":"crossref","first-page":"e1504","DOI":"10.1002\/wnan.1504","article-title":"Recent progress on fabrication and drug delivery applications of nanostructured hydroxyapatite","volume":"10","author":"Mondal","year":"2018","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"1\u20133","key":"10.1016\/j.xphs.2021.08.034_bib0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.colsurfa.2007.08.036","article-title":"Effect of calcium ions on transformation brushite to hydroxyapatite in aqueous solutions","volume":"316","author":"tulajterov\u00e1","year":"2008","journal-title":"Colloids Surf A"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.034_bib0037","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.msec.2017.11.012","article-title":"Hydroxyapatite\/mesoporous silica coated gold nanorods with improved degradability as a multi-responsive drug delivery platform","volume":"83","author":"Zhixuan Song","year":"2018","journal-title":"Mater Sci Eng C"},{"issue":"47","key":"10.1016\/j.xphs.2021.08.034_bib0038","doi-asserted-by":"crossref","first-page":"20033","DOI":"10.1039\/C5NR06837A","article-title":"Bio-nanoplatforms based on carbon dots conjugating with F-substituted nano-hydroxyapatite for cellular imaging","volume":"7","author":"Zhao","year":"2015","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.xphs.2021.08.034_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08982104.2018.1529792","article-title":"PEG-PCL modification and intestinal sustained-release of solid lipid nanoparticles for improving oral bioavailability of 2-methoxyestradiol","volume":"29","author":"Xing","year":"2019","journal-title":"J Liposome Res"},{"key":"10.1016\/j.xphs.2021.08.034_bib0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejpb.2017.04.003","article-title":"High oral bioavailability of 2-methoxyestradiol in PEG-PLGA micelles-microspheres for cancer therapy","volume":"117","author":"Guo","year":"2017","journal-title":"Eur J Pharma Biopharma"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.034_bib0042","first-page":"36","article-title":"Effect of hesperetin on the level of reactive oxygen species in H9C2 cardiomyocytes which induced by lipopolysaccharides","volume":"11","author":"Deng","year":"2014","journal-title":"J Med Res"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.034_bib0043","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA\u00a0 Cancer J Clin"},{"issue":"16","key":"10.1016\/j.xphs.2021.08.034_bib0044","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/smll.201000538","article-title":"Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals","volume":"6","author":"Lu","year":"2010","journal-title":"Small"},{"issue":"10","key":"10.1016\/j.xphs.2021.08.034_bib0045","doi-asserted-by":"crossref","first-page":"1805730","DOI":"10.1002\/adma.201805730","article-title":"Degradability and clearance of inorganic nanoparticles for biomedical applications","volume":"31","author":"Yang","year":"2019","journal-title":"Adv Mater"},{"issue":"13","key":"10.1016\/j.xphs.2021.08.034_bib0046","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201900716","article-title":"Oligo hyaluronan coated silica\/hydroxyapatite degradable nanoparticles for targeted cancer treatment","volume":"6","author":"Kang","year":"2019","journal-title":"Adv Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921004676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921004676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:36:26Z","timestamp":1758360986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921004676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0022354921004676"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.08.034","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual Responsive Hybrid Nanoparticle for Tumor Chemotherapy Combined with Photothermal Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}